Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $1.87 Million - $2.1 Million
-32,385 Reduced 21.64%
117,290 $6.81 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $446,288 - $495,533
7,005 Added 4.91%
149,675 $9.57 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $112,364 - $127,446
-1,710 Reduced 1.18%
142,670 $9.89 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $238,652 - $282,598
-3,485 Reduced 2.36%
144,380 $10.4 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $3,601 - $2.13 Million
27,705 Added 23.06%
147,865 $10.5 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $8.73 Million - $9.61 Million
120,160 New
120,160 $9.25 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $7.69 Million - $8.96 Million
-143,378 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $708,087 - $829,432
11,967 Added 9.11%
143,378 $8.48 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $4.16 Million - $4.53 Million
-67,165 Reduced 33.82%
131,411 $8.78 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $2.2 Million - $2.48 Million
-37,095 Reduced 15.74%
198,576 $12.5 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $1.06 Million - $1.2 Million
18,321 Added 8.43%
235,671 $14.6 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $12 Million - $13.3 Million
208,650 Added 2398.28%
217,350 $13.1 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $10.7 Million - $11.9 Million
-186,905 Reduced 95.55%
8,700 $441,000
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $9.18 Million - $10.7 Million
167,545 Added 597.1%
195,605 $11.5 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $47,560 - $69,115
1,025 Added 3.79%
28,060 $1.56 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $902,265 - $1.18 Million
18,335 Added 210.75%
27,035 $1.74 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $21,194 - $23,436
-475 Reduced 5.18%
8,700 $395,000
Q3 2017

Oct 18, 2017

BUY
$55.23 - $63.74 $506,735 - $584,814
9,175
9,175 $585,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.